113 related articles for article (PubMed ID: 14599950)
21. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
Jeng KS; Sheen IS; Tsai YC
Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
[TBL] [Abstract][Full Text] [Related]
22. Changes and significance of circulating hepatocellular carcinoma cells in recurrent hepatocellular carcinoma patients after combined treatment.
Liu Y; Wu M; Qian G; Zhang B; Chen H; Fu J; Huang C
Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):40-1. PubMed ID: 11242135
[TBL] [Abstract][Full Text] [Related]
23. [The influence of tumor cells spreading in blood to relapse and distant metastasis of hepatocellular carcinoma after surgery].
LIU Y; ZHANG GT; WU MC
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1583-5. PubMed ID: 19094658
[TBL] [Abstract][Full Text] [Related]
24. Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound.
Wu F; Wang ZB; Jin CB; Zhang JP; Chen WZ; Bai J; Zou JZ; Zhu H
Ultrasound Med Biol; 2004 Apr; 30(4):511-7. PubMed ID: 15121253
[TBL] [Abstract][Full Text] [Related]
25. Detection of hepatocellular carcinoma cells in peripheral venous blood and its significance.
Hu C; Yang D
Chin Med J (Engl); 1998 Feb; 111(2):183-6. PubMed ID: 10374385
[No Abstract] [Full Text] [Related]
26. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
[TBL] [Abstract][Full Text] [Related]
27. [AFP mRNA expression in peripheral blood correlates with metastasis of hepatocellular carcinoma].
Jiang Y; Yang Z; Hu J
Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):38-41. PubMed ID: 11776794
[TBL] [Abstract][Full Text] [Related]
28. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
30. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
[TBL] [Abstract][Full Text] [Related]
31. Significance of detecting circulating hepatocellular carcinoma cells in peripheral blood of hepatocellular carcinoma patients by nested reverse transcription-polymerase chain reaction and its clinical value: a retrospective study.
Liu Y; Wang YR; Wang L; Song RM; Zhou B; Song ZS
Tumori; 2014; 100(5):536-40. PubMed ID: 25343549
[TBL] [Abstract][Full Text] [Related]
32. Circulating tumorous cells in patients with hepatocellular carcinoma. Clinical impact and future directions.
Paterlini-Bréchot P; Vona G; Bréchot C
Semin Cancer Biol; 2000 Jun; 10(3):241-9. PubMed ID: 10936072
[TBL] [Abstract][Full Text] [Related]
33. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
[TBL] [Abstract][Full Text] [Related]
34. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
35. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
[TBL] [Abstract][Full Text] [Related]
36. [Isolated tumor cells in primary malignant liver tumors].
Tannapfel A; Geissler F; Witzigmann H; Wittekind C
Zentralbl Chir; 2000; 125(7):602-5. PubMed ID: 10960969
[TBL] [Abstract][Full Text] [Related]
37. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
J Exp Clin Cancer Res; 2005 Jun; 24(2):265-71. PubMed ID: 16110760
[TBL] [Abstract][Full Text] [Related]
38. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
Jeng KS; Sheen IS; Tsai YC
Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142
[TBL] [Abstract][Full Text] [Related]
39. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
40. Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
Wang YL; Li G; Wu D; Liu YW; Yao Z
Transplant Proc; 2007; 39(1):166-8. PubMed ID: 17275497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]